• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

mike523's Profile

Avatar:

Membership:

Premium

Person Marks:

37

Total Posts:

1061

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

02/20/2012 3:40:51 PM

Personal info

1

1

2

2

Recent Articles

• Emerging Opportunities in Alpha-synuclein Inhibitors Market Growth
• FIBRA Prologis Reports Strong Q2 2025 Earnings Insights
• Key Insights for Investors Ahead of Meta Platforms Q2 Earnings
• Abercrombie & Fitch: An In-Depth Look at Its Value Prospects
• Strategic Decisions Following Bankruptcy: Nano Dimension Insights
• Qualigen Therapeutics Updates on Nasdaq Listing Compliance Efforts
• FAT Brands Set to Reveal Second Quarter Financial Insights
• Unlocking Long-Term Growth: The Journey of Texas Instruments
• Grupo Comercial Chedraui Reports Strong Second Quarter Performance
• Empowering Recovery: Join the Opioid Summit for Veterans
• Market Insights: Key Earnings Reports and Trends Ahead
• Understanding the Centene Corporation Class Action Lawsuit
• Understanding the Recent Legal Challenges Facing Reddit, Inc.
• Investors Rally Behind Hims & Hers Amid Class Action Lawsuit
• Brown & Brown, Inc. Reports Significant Growth in Q2 2025
• Investor Alert: Legal Action for Sarepta Therapeutics Losses
• Upcoming Earnings Call for Maravai LifeSciences: Key Insights
• Class Action Notice: Hims & Hers Investors Can Recover Losses
• Investors Alert: Hims & Hers Faces Class Action Lawsuit Risks
• Sarepta Therapeutics Facing Class Action Lawsuit Amid Concerns
• Analyzing CRH Inc's Earnings Performance and Market Trends
• How New Regulations Impact Startups in the Stablecoin Market
• Paramount Global Prepares for Q2 2025 Results Announcement
• SDGE Honored With Two Awards for Excellence in Operations
• Energizer Holdings Announces Exciting Dividend for Investors
• Investors Invited to Lead Class Action Against Rocket Pharmaceuticals
• Chris Hannan Joins Jones Walker's Maritime Practice in New Orleans
• Howard Hughes Holdings Reports Strong Sales in Top Communities
• Enovix Corporation Announces Early Warrant Expiration Details
• Tempus AI Inc Faces Class Action Amid Accusations of Fraud
• Enovix Corp Gears Up for Earnings, Manufacturing Goals Tested
• iRobot Corporation Faces Class Action Risk: What Investors Should Know
• Reckitt Benckiser Group PLC Class Action Overview for Investors
• The Incredible Growth of HubSpot: A $100 Investment Journey
• Cadence Design Systems Reports Strong Earnings and Outlook
• Leadership Transition at MSC Industrial Supply Co. Amid Growth
• Scotch Brand Commemorates a Century of Innovation and Trust
• Capricor Therapeutics Securities Fraud: Join the Class Action
• A2LA Expands Operations with New Office in Boulder, CO
• BlackLine Strengthens Leadership with Greg Hughes Appointment to Board
• PepGen Inc. Legal Insights: Recover Your Investment Losses
• Hims & Hers Health Faces Legal Challenges Over Wegovy Marketing
• iSpecimen Inc. Successfully Closed $4 Million Offering
• Celebrating ASLA's Recognition for Leadership in Landscape Architecture
• Centene Corporation's Q2 Results Spark Class Action Concerns
• Azerion Leadership Enhances Company Trust Through Share Acquisitions
• Azerion Leadership Team Enhances Commitment with Share Purchases
• Boeing Stock: What to Expect Ahead of Earnings Announcement
• Universal Safety Products, Inc. Reports Strong Financial Growth
• Veralto Achieves 6.4% Sales Growth in Recent Quarter